Early Stage Venture Aegle Therapeutics Raises Series A of $6500000

September 28, 2020

About Aegle Therapeutics

Aegle Therapeutics is a clinical-stage regenerative medicine company that develops novel therapeutics.

Website: Learn more on Aegle Therapeutics’s website

Crunchbase: Follow on Crunchbase

[adace-ad id=”4426″]

Series A – Aegle Therapeutics

Amount Raised6500000 USD
Announced Date2020-09-29
Equity Only FundingYes
Organization LocationMiami, Florida, United States, North America
Funding StatusEarly Stage Venture
Number of Funding Rounds3
Lead Investors
Number of Investors5
Number of Partner Investors1
Previous Story

Early Stage Venture Etrio Raises Series A of $3000000

Next Story

Early Stage Venture Easy Solar Raises Series A of $3000000